-
Competition watch dog raps pharma sector for non-competitive market moves
expressbpd
November 10, 2018
India is probably the only or one of the few pharma markets where we have a third category (branded generics) in addition to branded and generic medicines. The CCI’s recent policy note on ‘Making Markets Work for Affordable Healthcare’, comes down heavily
-
Insights and learnings galore at Pharma CXO Summit 2017
expressbpd
November 13, 2017
The second day of the inaugural Pharma CXO Summit saw experts continues their discussions and deliberations on ‘Leveraging global traceability for sustainable business and growth’.
-
CPhI Korea reveals growth of domestic pharma companies in South Korea
biospectrumasia
September 26, 2017
International partnerships are quickly becoming a driving force for South Korea’s pharma sector.
-
LifeArc spends Keytruda cash on R&D ignored by pharma
pharmaphorum
June 15, 2017
Medical research charity LifeArc is to spend up to half a billion pounds in royalties earned from cancer blockbuster Keytruda, to fund cutting edge R&D that big pharma considers too risky.
-
Japanese pharma expects 17% growth throughout 2017
pharmafile
April 26, 2017
Pharma companies attending CPhI Japan are expecting a 17% growth of the country’s market throughout the year...
-
Janssen acquires over 90% of Actelion
pharmafile
April 25, 2017
Actelion has revealed that, following the wrap of its $30 billion deal in January, Janssen Holding has acquired ...
-
GW’s Epidiolex on track for LGS filing mid-year
pharmatimes
April 21, 2017
GW Pharma’s Epidiolex has impressed again in a late-stage trial involving patients with the rare form of epilepsy Lennox-Gastaut
-
EMA issues positive opinion for EUSA Pharma's Dinutuximab beta to treat neuroblastoma
pharmaceutical-technology
March 30, 2017
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favour of marketing authorisation for EUSA Pharma’s ...